Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Herpesvirus 6, Human | 5 | 2019 | 162 | 0.66 | Why? |
| Hematopoietic Stem Cell Transplantation | 9 | 2019 | 2426 | 0.54 | Why? |
| Herpesvirus 2, Human | 4 | 2017 | 137 | 0.46 | Why? |
| Roseolovirus Infections | 4 | 2019 | 131 | 0.42 | Why? |
| Herpes Genitalis | 3 | 2017 | 90 | 0.32 | Why? |
| Adenoviridae Infections | 2 | 2018 | 150 | 0.32 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 154 | 0.31 | Why? |
| Caliciviridae Infections | 2 | 2019 | 229 | 0.29 | Why? |
| Simian Immunodeficiency Virus | 2 | 2018 | 251 | 0.29 | Why? |
| Herpesvirus 1, Human | 2 | 2018 | 286 | 0.28 | Why? |
| Norovirus | 2 | 2019 | 294 | 0.28 | Why? |
| DNA, Viral | 7 | 2019 | 2521 | 0.27 | Why? |
| Herpes Simplex | 2 | 2018 | 272 | 0.27 | Why? |
| Clinical Laboratory Techniques | 10 | 2021 | 23402 | 0.27 | Why? |
| Metagenomics | 2 | 2020 | 823 | 0.26 | Why? |
| Cytomegalovirus | 3 | 2017 | 600 | 0.26 | Why? |
| Viremia | 3 | 2018 | 1020 | 0.24 | Why? |
| Nuclear Matrix-Associated Proteins | 1 | 2021 | 50 | 0.22 | Why? |
| Specimen Handling | 4 | 2021 | 6190 | 0.22 | Why? |
| Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.22 | Why? |
| Nuclear Pore Complex Proteins | 1 | 2021 | 53 | 0.22 | Why? |
| Gene Fusion | 1 | 2020 | 25 | 0.21 | Why? |
| Washington | 6 | 2021 | 1722 | 0.21 | Why? |
| Real-Time Polymerase Chain Reaction | 7 | 2021 | 11367 | 0.21 | Why? |
| Oligonucleotide Probes | 1 | 2020 | 88 | 0.21 | Why? |
| Molecular Diagnostic Techniques | 3 | 2020 | 4239 | 0.20 | Why? |
| DNA Primers | 3 | 2020 | 1170 | 0.20 | Why? |
| Viral Load | 9 | 2020 | 15850 | 0.19 | Why? |
| Replication Origin | 1 | 2018 | 16 | 0.19 | Why? |
| Tandem Repeat Sequences | 1 | 2018 | 78 | 0.19 | Why? |
| Cell Nucleus | 1 | 2021 | 399 | 0.18 | Why? |
| RNA, Viral | 9 | 2021 | 32276 | 0.18 | Why? |
| Genomic Instability | 1 | 2018 | 80 | 0.18 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.18 | Why? |
| Inheritance Patterns | 1 | 2017 | 20 | 0.17 | Why? |
| Chromosomes, Human | 1 | 2017 | 38 | 0.17 | Why? |
| Whole-Body Irradiation | 1 | 2017 | 42 | 0.17 | Why? |
| Infectious Mononucleosis | 1 | 2017 | 35 | 0.17 | Why? |
| Ganciclovir | 1 | 2017 | 97 | 0.16 | Why? |
| Viral Proteins | 3 | 2021 | 7370 | 0.16 | Why? |
| Cytomegalovirus Infections | 3 | 2018 | 667 | 0.16 | Why? |
| Receptors, CCR5 | 1 | 2018 | 186 | 0.16 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.16 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.15 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.15 | Why? |
| Virus Shedding | 3 | 2017 | 5834 | 0.15 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.15 | Why? |
| Simplexvirus | 1 | 2015 | 124 | 0.14 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.14 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.14 | Why? |
| Transplantation Conditioning | 1 | 2017 | 323 | 0.14 | Why? |
| Virus Cultivation | 1 | 2018 | 579 | 0.14 | Why? |
| Betacoronavirus | 14 | 2020 | 204454 | 0.13 | Why? |
| Genome, Viral | 6 | 2021 | 13157 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Sensitivity and Specificity | 10 | 2021 | 22971 | 0.12 | Why? |
| Phylogeny | 9 | 2021 | 13341 | 0.12 | Why? |
| Mouth | 1 | 2017 | 622 | 0.12 | Why? |
| DNA | 1 | 2018 | 778 | 0.12 | Why? |
| Graft vs Host Disease | 3 | 2017 | 501 | 0.11 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 2309 | 0.11 | Why? |
| Genes, Viral | 1 | 2017 | 1428 | 0.11 | Why? |
| Transplant Recipients | 3 | 2018 | 4982 | 0.11 | Why? |
| Organ Transplantation | 2 | 2018 | 2616 | 0.11 | Why? |
| Macaca nemestrina | 3 | 2018 | 71 | 0.10 | Why? |
| Opportunistic Infections | 1 | 2017 | 602 | 0.10 | Why? |
| BK Virus | 2 | 2017 | 135 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Recombination, Genetic | 1 | 2017 | 1265 | 0.10 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.10 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.09 | Why? |
| Likelihood Functions | 2 | 2020 | 719 | 0.09 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.09 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.08 | Why? |
| Nasopharynx | 6 | 2020 | 10224 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Transplantation, Autologous | 2 | 2018 | 364 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.08 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 13720 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Virus Latency | 2 | 2018 | 251 | 0.07 | Why? |
| South America | 2 | 2017 | 565 | 0.07 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.07 | Why? |
| Cystitis | 1 | 2004 | 45 | 0.07 | Why? |
| Humans | 42 | 2022 | 930598 | 0.07 | Why? |
| Herpesvirus 4, Human | 2 | 2017 | 387 | 0.07 | Why? |
| fas Receptor | 1 | 2003 | 85 | 0.06 | Why? |
| Cross-Linking Reagents | 1 | 2003 | 91 | 0.06 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.06 | Why? |
| Antiviral Agents | 4 | 2020 | 41703 | 0.06 | Why? |
| Polyomavirus Infections | 1 | 2004 | 156 | 0.06 | Why? |
| Genotype | 3 | 2021 | 4697 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3633 | 0.06 | Why? |
| Uganda | 2 | 2017 | 1057 | 0.06 | Why? |
| Adoptive Transfer | 1 | 2003 | 250 | 0.06 | Why? |
| Virus Replication | 3 | 2018 | 14331 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Polymerase Chain Reaction | 3 | 2020 | 6740 | 0.06 | Why? |
| Adenoviridae | 2 | 2018 | 1151 | 0.06 | Why? |
| Travel | 1 | 2020 | 7220 | 0.05 | Why? |
| High-Throughput Screening Assays | 2 | 2020 | 1783 | 0.05 | Why? |
| Buffers | 1 | 2020 | 82 | 0.05 | Why? |
| Active Transport, Cell Nucleus | 1 | 2021 | 203 | 0.05 | Why? |
| Kinetics | 2 | 2020 | 3238 | 0.05 | Why? |
| Young Adult | 10 | 2020 | 93724 | 0.05 | Why? |
| Fisheries | 1 | 2020 | 57 | 0.05 | Why? |
| Ribosomal Proteins | 1 | 2020 | 94 | 0.05 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.05 | Why? |
| Sequence Analysis, DNA | 2 | 2020 | 2830 | 0.05 | Why? |
| Hematopoietic Stem Cells | 2 | 2018 | 321 | 0.05 | Why? |
| Male | 20 | 2020 | 367725 | 0.05 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.05 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.05 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2022 | 265 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Los Angeles | 1 | 2022 | 647 | 0.05 | Why? |
| Anti-Retroviral Agents | 2 | 2018 | 1099 | 0.05 | Why? |
| Connecticut | 1 | 2020 | 547 | 0.04 | Why? |
| Female | 18 | 2020 | 380317 | 0.04 | Why? |
| Nucleic Acid Hybridization | 1 | 2018 | 140 | 0.04 | Why? |
| Africa | 2 | 2017 | 2986 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2021 | 4020 | 0.04 | Why? |
| Double-Blind Method | 2 | 2020 | 5988 | 0.04 | Why? |
| Adult | 14 | 2020 | 244371 | 0.04 | Why? |
| Lentivirus Infections | 1 | 2017 | 47 | 0.04 | Why? |
| Metagenome | 1 | 2019 | 268 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2020 | 536 | 0.04 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Genitalia | 1 | 2017 | 98 | 0.04 | Why? |
| Unrelated Donors | 1 | 2017 | 187 | 0.04 | Why? |
| Enterovirus | 1 | 2020 | 402 | 0.04 | Why? |
| Wound Healing | 1 | 2020 | 424 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Sequence Homology | 1 | 2017 | 448 | 0.04 | Why? |
| Middle Aged | 13 | 2020 | 270681 | 0.04 | Why? |
| Cord Blood Stem Cell Transplantation | 1 | 2017 | 143 | 0.04 | Why? |
| Retrospective Studies | 7 | 2022 | 105322 | 0.04 | Why? |
| Alleles | 1 | 2021 | 1557 | 0.04 | Why? |
| Evolution, Molecular | 2 | 2019 | 3691 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.03 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.03 | Why? |
| Cohort Studies | 4 | 2019 | 36005 | 0.03 | Why? |
| Base Sequence | 2 | 2018 | 3581 | 0.03 | Why? |
| Transplantation, Homologous | 1 | 2017 | 757 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.03 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.03 | Why? |
| Epstein-Barr Virus Infections | 1 | 2018 | 366 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.03 | Why? |
| Apoptosis | 1 | 2003 | 2335 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.03 | Why? |
| United States | 4 | 2020 | 46150 | 0.03 | Why? |
| Ships | 1 | 2020 | 1046 | 0.03 | Why? |
| North America | 1 | 2017 | 1400 | 0.03 | Why? |
| Hemorrhage | 1 | 2004 | 3013 | 0.03 | Why? |
| Child | 5 | 2020 | 70012 | 0.03 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2020 | 2290 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Infant | 3 | 2018 | 30274 | 0.03 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Risk Factors | 5 | 2018 | 71621 | 0.02 | Why? |
| Aged | 7 | 2020 | 215776 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.02 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Seroconversion | 1 | 2017 | 2515 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.02 | Why? |
| Animals | 4 | 2021 | 78931 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2003 | 6670 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Patient Compliance | 1 | 2014 | 1468 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.02 | Why? |
| Retroviridae | 1 | 2003 | 49 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Organic Chemicals | 1 | 2003 | 90 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Transgenes | 1 | 2003 | 227 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Drug Stability | 1 | 2002 | 236 | 0.01 | Why? |
| Drug Storage | 1 | 2002 | 125 | 0.01 | Why? |
| Models, Animal | 1 | 2003 | 788 | 0.01 | Why? |
| In Vitro Techniques | 1 | 2003 | 1027 | 0.01 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2002 | 260 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2014 | 9893 | 0.01 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.01 | Why? |
| Cell Survival | 1 | 2003 | 1581 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2003 | 3198 | 0.01 | Why? |
| Cross Infection | 1 | 2019 | 8675 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2014 | 5002 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2003 | 2262 | 0.01 | Why? |
| Amino Acid Sequence | 1 | 2003 | 6049 | 0.01 | Why? |
| Epitopes | 1 | 2003 | 4113 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |